CompletedNot Applicable

Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric Bypass

United States45 participantsStarted 2008-12

Plain-language summary

The objective of this study is to identify the incidence rate; describe the risk factors, clinical presentation, and endoscopic treatment; assess the morbidity, mortality, and overall performance of the management of patients with actively bleeding marginal ulcers after Roux-en-Y gastric bypass (RYGB) surgery.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients status post laparoscopic RYGB surgery with active gastrointestinal hemorrhage secondary to marginal ulcer Exclusion Criteria: * bleeding marginal ulcers after other bariatric procedures * staple-line bleeding after RYGB * iron-deficiency anemia (chronic) secondary to non-actively bleeding marginal ulcer after RYGB * other sources of GI bleeding different from marginal ulcer such as from staple-lines, complicated PUD, and other surgical and medical causes of GI hemorrhage * missing records and/or unreachable patients with scant information for analysis

What they're measuring

Morbidity and mortality, overall

Timeframe: throughout follow-up

re-bleeding, gastrointestinal hemorrhage secondary to marginal ulceration

Timeframe: throughout follow-up

marginal ulcer recurrence

Timeframe: at last follow-up

Symptom resolution, marginal ulcer

Timeframe: at last follow-up

Trial details

NCT IDNCT01040416

SponsorUniversity of California, San Francisco

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2009-12

View on ClinicalTrials.gov More Bleeding Marginal Ulcer trials